Display options
Cite
Tahara K, Fujimoto S, Fujii F, et al. Quantum Dot-Loaded Liposomes to Evaluate the Behavior of Drug Carriers after Oral Administration. J Pharm (Cairo). 2013;2013:848275doi: 10.1155/2013/848275.
Tahara, K., Fujimoto, S., Fujii, F., Tozuka, Y., Jin, T., & Takeuchi, H. (2013). Quantum Dot-Loaded Liposomes to Evaluate the Behavior of Drug Carriers after Oral Administration. Journal of pharmaceutics, 2013848275. https://doi.org/10.1155/2013/848275
Tahara, Kohei, et al. "Quantum Dot-Loaded Liposomes to Evaluate the Behavior of Drug Carriers after Oral Administration." Journal of pharmaceutics vol. 2013 (2013): 848275. doi: https://doi.org/10.1155/2013/848275
Tahara K, Fujimoto S, Fujii F, Tozuka Y, Jin T, Takeuchi H. Quantum Dot-Loaded Liposomes to Evaluate the Behavior of Drug Carriers after Oral Administration. J Pharm (Cairo). 2013;2013:848275. doi: 10.1155/2013/848275. Epub 2013 Jul 18. PMID: 26555997; PMCID: PMC4590795.
Copy Download .nbib Format: NLM
Share it on

J Pharm (Cairo). 2013;2013:848275. doi: 10.1155/2013/848275. Epub 2013 Jul 18.

Quantum Dot-Loaded Liposomes to Evaluate the Behavior of Drug Carriers after Oral Administration.

Journal of pharmaceutics

Kohei Tahara, Shiho Fujimoto, Fumihiko Fujii, Yuichi Tozuka, Takashi Jin, Hirofumi Takeuchi

Affiliations

  1. Laboratory of Pharmaceutical Engineering, Gifu Pharmaceutical University, 1-25-4 Daigaku-Nishi, Gifu 501-1196, Japan.
  2. Immunology Frontier Research Center, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
  3. Laboratory of Pharmaceutical Engineering, Gifu Pharmaceutical University, 1-25-4 Daigaku-Nishi, Gifu 501-1196, Japan ; Laboratory of Formulation Design and Pharmaceutical Technology, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan.
  4. Immunology Frontier Research Center, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan ; Quantitative Biology Center, RIKEN, 6-2-3 Furuedai, Suita, Osaka 565-0874, Japan.

PMID: 26555997 PMCID: PMC4590795 DOI: 10.1155/2013/848275

Abstract

We have developed submicron-sized liposomes modified with a mucoadhesive polymer to enhance peptide drug absorption after oral administration. Liposomal behavior in the gastrointestinal tract is a critical factor for effective peptide drug delivery. The purpose of this study was to prepare quantum dot- (QD-) loaded submicron-sized liposomes and examine liposomal behavior in the body after oral administration using in vivo fluorescence imaging. Two types of CdSe/CdZnS QDs with different surface properties were used: hydrophobic (unmodified) QDs and hydrophilic QDs with glutathione (GSH) surface modifications. QD- and GSH-QD-loaded liposomes were prepared by a thin film hydration method. Transmission electron microscopy revealed that QDs were embedded in the liposomal lipid bilayer. Conversely, GSH-QDs were present in the inner aqueous phase. Some of the GSH-QDs were electrostatically associated with the lipid membrane of stearylamine-bearing cationic liposomes. QD-loaded liposomes were detected in Caco-2 cells after exposure to the liposomes, and these liposomes were not toxic to the Caco-2 cells. Furthermore, we evaluated the in vivo bioadhesion and intestinal penetration of orally administered QD-loaded liposomes by observing the intestinal segment using confocal laser scanning microscopy.

References

  1. Int J Pharm. 2012 Oct 15;436(1-2):564-7 - PubMed
  2. Bioconjug Chem. 2010 Aug 18;21(8):1465-72 - PubMed
  3. Med Res Rev. 2009 Jan;29(1):196-212 - PubMed
  4. Sensors (Basel). 2009;9(11):9332-64 - PubMed
  5. Chem Commun (Camb). 2011 Mar 28;47(12):3442-4 - PubMed
  6. Science. 2005 Jan 28;307(5709):538-44 - PubMed
  7. Int J Pharm. 2005 Oct 13;303(1-2):160-70 - PubMed
  8. Eur J Pharm Biopharm. 2011 Feb;77(2):216-24 - PubMed
  9. J Pharm Sci. 2003 Oct;92(10):2090-7 - PubMed
  10. Adv Drug Deliv Rev. 2005 Nov 3;57(11):1583-94 - PubMed
  11. Nano Res. 2009 Jun 1;2(6):500-508 - PubMed
  12. Int J Pharm. 2011 Sep 20;416(2):443-7 - PubMed
  13. Adv Drug Deliv Rev. 2001 Mar 23;47(1):39-54 - PubMed
  14. Science. 2002 Nov 29;298(5599):1759-62 - PubMed
  15. Nat Rev Drug Discov. 2005 Feb;4(2):145-60 - PubMed
  16. Eur J Pharm Biopharm. 2012 Feb;80(2):340-6 - PubMed
  17. Expert Opin Drug Deliv. 2008 Jan;5(1):25-44 - PubMed
  18. ACS Nano. 2008 Mar;2(3):408-18 - PubMed
  19. Adv Drug Deliv Rev. 2005 Jun 15;57(8):1087-108 - PubMed
  20. Int J Mol Sci. 2008 Oct;9(10):2044-61 - PubMed

Publication Types